Calcium Citrate Benefits Challenged
A recently published study showed no correlation between urinary pH and citrate concentration.
A recently published study showed no correlation between urinary pH and citrate concentration.
Roche announced that the FDA has approved Mircera (methoxy polyethylene glycol-epoetin beta) for the treatment of anemia associated with CKD in adults, including dialysis patients and patients not on dialysis.
Crestor (rosuvastatin calcium) from AstraZeneca has received a new indication as an adjunct to diet to slow the progression of atherosclerosis in adult patients with elevated cholesterol, differentiating it from competitors in the cholesterol-lowering marketplace.
DexCom, Inc., of San Diego, announced that it has received approval to calibrate Seven, its seven-day continuous glucose monitoring system, using any FDA-cleared blood glucose meter.
The FDA has cleared the antihypertensive agent Avalide (irbesartan and hydrochlorothiazide) as the first combination therapy for initial use in patients who are likely to need multiple drugs to achieve their BP goals.
Ureteroscopy (URS) is appropriate for the surgical treatment of ureteral stones regardless of their location in the ureter, according to a new guideline document developed by a panel convened by the American Urological Association (AUA) and the European Association of Urology (EAU).
WASHINGTON, D.C.—Men with a history of infertility may be at increased risk of testicular cancer, according to the largest study to date looking at this issue.
SAN FRANCISCO—Arteriovenous fistulas (AVF) are associated with less chronic inflammation than catheters in adult and pediatric hemodialysis patients, according to a new study. The study is the first to investigate this association in both adults and children.
SAN FRANCISCO—The use of central venous catheters (CVC) for dialysis access has not changed despite an increase in arteriovenous fistula (AVF) use, researchers reported here during Renal Week 2007.
SAN FRANCISCO—Nocturnal hemodialysis (NHD) offers superior calcium-phosphate control when compared with conventional hemodialysis (CHD), suggesting that NHD could enhance bone protection, according to Canadian researchers.